These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26301077)

  • 1. Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.
    Law S; Haddad PM; Chaudhry IB; Husain N; Drake RJ; Flanagan RJ; David AS; Patel MX
    Ther Adv Psychopharmacol; 2015 Aug; 5(4):214-23. PubMed ID: 26301077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring.
    Best-Shaw L; Gudbrandsen M; Nagar J; Rose D; David AS; Patel MX
    Ther Drug Monit; 2014 Aug; 36(4):486-93. PubMed ID: 24384695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European psychiatric association (EPA) - early career psychiatrists committee survey on trainees' and early-career psychiatrists' attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment.
    Schoretsanitis G; Correll CU; Agorastos A; Compaired Sanchez A; Erzin G; Grigoras RM; Grizelj Benussi M; Gondek TM; Guloksuz S; Højlund M; Jerotic S; Kilic O; Metaj E; Sidhu DS; Skandali N; Skuhareuski A; Tveito M; Wolthusen RPF; ; Chumakov E; de Filippis R
    World J Biol Psychiatry; 2024 Jul; 25(6):342-351. PubMed ID: 38905131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatrists' Attitude and Use of Second-generation Antipsychotics for the Treatment of Schizophrenia in Taiwan.
    Chen CK; Su HH; Sun IW
    East Asian Arch Psychiatry; 2017 Sep; 27(3):91-6. PubMed ID: 28993541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
    Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists' Attitudes in Taiwan.
    Yen K; Liu CC; Lin YT; Chien YL; Hsieh MH; Liu CM; Hwang TJ; Liao WH; Hwu HG
    Neuropsychiatr Dis Treat; 2022; 18():465-475. PubMed ID: 35261544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring: perspectives of psychiatrists in Turkey.
    Eryılmaz G; Hızlı Sayar G; Gül IG; Noyan CO; Özten E; Darçın AE; Yorbik Ö; Dilbaz N
    Int J Psychiatry Clin Pract; 2015 Mar; 19(1):60-4. PubMed ID: 25363201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consultant psychiatrists' experiences of and attitudes towards shared decision making in antipsychotic prescribing, a qualitative study.
    Shepherd A; Shorthouse O; Gask L
    BMC Psychiatry; 2014 May; 14():127. PubMed ID: 24886121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
    Sugawara N; Yasui-Furukori N; Yamazaki M; Shimoda K; Mori T; Sugai T; Suzuki Y; Someya T
    PLoS One; 2014; 9(1):e86826. PubMed ID: 24466260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.
    Schoretsanitis G; Kane JM; Correll CU; Marder SR; Citrome L; Newcomer JW; Robinson DG; Goff DC; Kelly DL; Freudenreich O; Piacentino D; Paulzen M; Conca A; Zernig G; Haen E; Baumann P; Hiemke C; Gründer G; ; Pharmakopsychiatrie TTDMTFOTAFNU
    J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32433836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    James BO; Omoaregba JO; Raji SO; Imishue OE; Okonoda KM; Nyamali YI; Famuyiwa PA; Correll CU
    Psychiatry Res; 2017 Feb; 248():134-139. PubMed ID: 28063386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Clinical Experience on Early Career Psychiatrists' Beliefs and Attitudes Towards Older Psychiatric Patients.
    Fekih-Romdhane F; Tira S; Ghazouani N; Ben Ali S; Cheour M
    Community Ment Health J; 2020 Oct; 56(7):1344-1353. PubMed ID: 32026217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatrists' decision making between branded and generic drugs.
    Hamann J; Mendel R; Kissling W; Leucht S
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):686-90. PubMed ID: 23021566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatrists' self-reported adherence to evidence-based prescribing practices in the treatment of schizophrenia.
    Young GJ; Mohr DC; Meterko M; Seibert MN; McGlynn G
    Psychiatr Serv; 2006 Jan; 57(1):130-2. PubMed ID: 16399975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of psychiatrists' expectations of clinical pharmacists in Riyadh, Saudi Arabia.
    Al-Aqeel S; Al-Sabhan J; Al-Jumah K
    Med Princ Pract; 2012; 21(4):383-8. PubMed ID: 22248869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and attitudes about transcranial magnetic stimulation among psychiatrists in China.
    Deng J; Gong Y; Lin X; Bao Y; Sun H; Lu L
    BMC Psychiatry; 2020 Aug; 20(1):416. PubMed ID: 32831049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy in Taiwanese psychiatrists' preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey.
    Liu CH; Tsai PH; Chen CY
    Neuropsychiatr Dis Treat; 2018; 14():429-433. PubMed ID: 29440904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring for the metabolic side effects of second-generation antipsychotic medications: Psychiatrists' views and practices.
    Abdulhaq B; Dardas LA; Sami O
    Perspect Psychiatr Care; 2021 Jul; 57(3):1237-1243. PubMed ID: 33156542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.